Health Canada, Sep 17, 2001
2001-100
September 17, 2001
Warning
Health Canada market
survey confirms some products contain Aristolochic Acid
OTTAWA - Health Canada has
completed its analysis of 48 traditional Chinese medicines labelled to
contain Aristolochia, Akebia, Asarum, Clematis, Stephania, Caulus
Hocquaria Manshuriensis or MuTong that were collected during a random
market survey. Five of these products, in addition to the pediatric
product Tao Chih Pien reported previously, were found to contain
aristolochic acid. Consequently a recall of these products has been
issued.
Health Canada is advising consumers of traditional Chinese medicines to
read the product labels carefully and to not use products labelled to
contain the herbs listed above, as they may contain aristolochic acid.
Aristolochic acid can cause cancer, mutations in human cells and is known
to cause end-stage kidney failure. To date, no such incidents have been
reported in Canada.
Consumers who are currently using products labelled to contain the
above mentioned herbs are advised to discontinue use of the product and
contact their health care professionals.
Retailers, manufacturers and importers have been directed to recall
these products from the shelves. The five additional products found to
contain aristolochic acid are as follows:
- Du Xing Quin Li Pill (labelled to contain Clematis Chinesis Osbeck):
- Shen Yung Hu (labelled to contain Stephania Tetrandra):
- Chi Kuan Yen Wan (labelled to contain Fructus Aristolochiae)
- Kuanhsin Suhowan (labelled to contain Radix Aristolochiae)
- Gastropathy (labelled to contain Aristolochia Recurvilabra)
- (1 x 42 capsules)
- manufacturer: Zhengjiang Chinese Medicine Works, Kiangsu, China
On August 24, 2001, Health Canada issued a
warning for Tao Chih Pien,
the first of the products identified to contain aristolochic acid. There
is currently a stop sale order in effect for products labelled to contain
the above herbs, which will continue until further notice. Health Canada
is maintaining its work with the traditional Chinese medicine industry to
resolve issues relating to mislabelling of products and the substitution
of herbs in Chinese medicines.
The text in this article was prepared by Health Canada.